Search results for: Determining Value
Filter search results
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
14 April 2020
…a treatment. This paper discusses four uncertainty-related value elements: insurance value, real option value, the value of knowing, and the value of hope. The current state of empirical research supporting…
An Update on the EQ-5D-5L Value Set for England
22 August 2017
…on the implications of new value sets for HTA and other uses. 1. What is the current status of the EQ-5D-5L value set for England? An English value set for…
How do we Measure the “Value” in Value-Based care?
1 October 2020
Determining and defining value in health care is a persistent challenge in every country. To some extent, what constitutes value depends on perspective, e.g. a pharmaceutical company may view value…
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
1 July 2019
…also estimates the absolute social value added, measured by the sum of the consumer and producer surpluses. Study results aim to quantify the nature of value added by pharmaceutical innovation…
Moving the Needle on Value – OHE Launches Research on US Value-Based Healthcare
10 June 2019
At the recent ISPOR Annual Conference, OHE’s Chief Executive, Professor Graham Cookson announced a new programme of work on Value 2.0: Assessing the Value of US Healthcare to be funded…
Combination Therapies: A Step Forward to the Value Attribution Problem
4 January 2023
…launched), and complete (all value is apportioned to the constituent therapies). The co-authors presented challenges surrounding attributing value to CTs and the proposed outcome-based value attribution framework. The new solution…
Do child QALYs = adult QALYs? Five reasons why they might not
4 February 2020
…life for adults apply here too: what stated preference method is best? What sub-set of states to value? How to model the values? But aside from these common issues there…
Cornerstones of ‘Fair’ Drug Coverage
30 September 2020
…drug that represents a fair value as determined through value assessment, it is reasonable for payers to have all drugs on a higher cost-sharing level. Clinical Eligibility Criteria: (1) Clinical…
OHE’s AMR consultation response
21 November 2023
…learnings for establishing effective pull incentives in other jurisdictions. Notes 1 Value band 2: ‘critical value’ is defined as 70-79, so technically this dummy surpasses value band 2, but does…